“…Limb reports that the potential benefits from expanding the indications for proton therapy should be evaluated in randomised clinical trials 1. In proton therapy, in which advantages in radiation dose distribution are usually used to reduce the severity of long term morbidity, randomised clinical trials with an endpoint decades later may be problematic.…”